Bank of America
CYAD

Bank of America’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Bank of America’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-19,888
Closed -$1.09M – 7422
2015
Q4 		$1.09M Hold
19,888
– – ﹤0.01% 4307
2015
Q3 		$832K Buy
+19,888
New +$1.02M ﹤0.01% 4466

Other funds holding CYAD

RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Bank of America's CYAD Position: Q1 2016 in Review

Bank of America sold out of Celyad Oncology SA American Depositary Shares (CYAD) in Q1 2016, closing a stake of 19,888 shares — an estimated $1.09M sold.

Bank of America first reported a position in CYAD in Q3 2015 and held it in 2 quarters. The position peaked at $1.09M in Q4 2015. 8 funds tracked by Wall St. Rank hold CYAD as of Q1 2016.

  • Bank of America reported no remaining Celyad Oncology SA American Depositary Shares position as of Q1 2016 after selling out during the quarter.
  • Bank of America sold 19,888 Celyad Oncology SA American Depositary Shares shares in Q1 2016, an estimated $1.09M.
  • Bank of America first reported a position in Celyad Oncology SA American Depositary Shares in Q3 2015 and held it in 2 quarters.
  • Bank of America's Celyad Oncology SA American Depositary Shares position peaked at $1.09M in Q4 2015.
  • 8 funds tracked by Wall St. Rank held Celyad Oncology SA American Depositary Shares as of Q1 2016.

Based on Bank of America's 13F filing for Q1 2016, filed 13 May 2016.